1
|
Laue C, Stevens Y, van Erp M, Papazova E, Soeth E, Pannenbeckers A, Stolte E, Böhm R, Gall SL, Falourd X, Ballance S, Knutsen SH, Pinheiro I, Possemiers S, Ryan PM, Ross RP, Stanton C, Wells JM, van der Werf S, Mes JJ, Schrezenmeir J. Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial. Nutrients 2021; 13:2683. [PMID: 34444843 PMCID: PMC8400163 DOI: 10.3390/nu13082683] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 07/26/2021] [Accepted: 07/29/2021] [Indexed: 01/02/2023] Open
Abstract
Senior individuals can suffer from immunosenescence and novel strategies to bolster the immune response could contribute to healthy ageing. In this double-blind, randomised, controlled pilot trial, we investigated the ability of non-digestible polysaccharide (NPS) preparations to enhance the immune response in a human vaccination model. In total, 239 subjects (aged 50-79 years) were randomised to consume one of five different NPS (yeast β-glucan (YBG), shiitake β-glucan (SBG), oat β-glucan (OBG), arabinoxylan (AX), bacterial exopolysaccharide (EPS)) or control (CTRL) product daily for five weeks. After two weeks of intervention, subjects were vaccinated with seasonal influenza vaccine. The post-vaccination increases in haemagglutination inhibition antibody titres and seroprotection rate against the influenza strains were non-significantly enhanced in the NPS intervention groups compared to CTRL. Specifically, a trend towards a higher mean log2 fold increase was observed in the AX group (uncorrected p = 0.074) combined with a trend for an increased seroprotection rate, AX group (48.7%) compared to CTRL (25.6%) (uncorrected p = 0.057), for the influenza A H1N1 strain. Subjects consuming AX also had a reduced incidence of common colds compared to CTRL (1 vs. 8; p = 0.029 in Fisher exact test). No adverse effects of NPS consumption were reported. The findings of this pilot study warrant further research to study AX as an oral adjuvant to support vaccine efficacy.
Collapse
Affiliation(s)
- Christiane Laue
- Clinical Research Center Kiel, Kiel Center of Innovation and Technology, 24118 Kiel, Germany; (E.P.); (E.S.); (A.P.); (R.B.); (J.S.)
| | - Yala Stevens
- BioActor, Brightlands Health Campus, 6229 GS Maastricht, The Netherlands; (Y.S.); (M.v.E.)
| | - Monique van Erp
- BioActor, Brightlands Health Campus, 6229 GS Maastricht, The Netherlands; (Y.S.); (M.v.E.)
| | - Ekaterina Papazova
- Clinical Research Center Kiel, Kiel Center of Innovation and Technology, 24118 Kiel, Germany; (E.P.); (E.S.); (A.P.); (R.B.); (J.S.)
| | - Edlyn Soeth
- Clinical Research Center Kiel, Kiel Center of Innovation and Technology, 24118 Kiel, Germany; (E.P.); (E.S.); (A.P.); (R.B.); (J.S.)
| | - Angelika Pannenbeckers
- Clinical Research Center Kiel, Kiel Center of Innovation and Technology, 24118 Kiel, Germany; (E.P.); (E.S.); (A.P.); (R.B.); (J.S.)
| | - Ellen Stolte
- Host-Microbe Interactomics, Wageningen University & Research, 6708 WD Wageningen, The Netherlands; (E.S.); (J.M.W.)
| | - Ruwen Böhm
- Clinical Research Center Kiel, Kiel Center of Innovation and Technology, 24118 Kiel, Germany; (E.P.); (E.S.); (A.P.); (R.B.); (J.S.)
| | - Sophie Le Gall
- UR1268 BIA, INRA, 44316 Nantes, France; (S.L.G.); (X.F.)
| | - Xavier Falourd
- UR1268 BIA, INRA, 44316 Nantes, France; (S.L.G.); (X.F.)
| | - Simon Ballance
- Nofima, Norwegian Institute of Food Fisheries & Aquaculture Research , 1433 Ås, Norway; (S.B.); (S.H.K.)
| | - Svein H. Knutsen
- Nofima, Norwegian Institute of Food Fisheries & Aquaculture Research , 1433 Ås, Norway; (S.B.); (S.H.K.)
| | - Iris Pinheiro
- Prodigest, Technologiepark-Zwijnaarde, 9052 Ghent, Belgium; (I.P.); (S.P.)
| | - Sam Possemiers
- Prodigest, Technologiepark-Zwijnaarde, 9052 Ghent, Belgium; (I.P.); (S.P.)
| | - Paul M. Ryan
- Teagasc, Food Research Centre, Moorepark, Fermoy, Co., P61 C996 Cork, Ireland; (P.M.R.); (C.S.)
- APC Microbiome Ireland, University College Cork, T12 YT20 Cork, Ireland;
| | - R. Paul Ross
- APC Microbiome Ireland, University College Cork, T12 YT20 Cork, Ireland;
| | - Catherine Stanton
- Teagasc, Food Research Centre, Moorepark, Fermoy, Co., P61 C996 Cork, Ireland; (P.M.R.); (C.S.)
- APC Microbiome Ireland, University College Cork, T12 YT20 Cork, Ireland;
| | - Jerry M. Wells
- Host-Microbe Interactomics, Wageningen University & Research, 6708 WD Wageningen, The Netherlands; (E.S.); (J.M.W.)
| | | | - Jurriaan J. Mes
- Wageningen Food and Biobased Research, Wageningen University & Research, 6708 WG Wageningen, The Netherlands;
| | - Juergen Schrezenmeir
- Clinical Research Center Kiel, Kiel Center of Innovation and Technology, 24118 Kiel, Germany; (E.P.); (E.S.); (A.P.); (R.B.); (J.S.)
| |
Collapse
|
2
|
Velikova N, Mas N, Miguel-Romero L, Polo L, Stolte E, Zaccaria E, Cao R, Taverne N, Murguía JR, Martinez-Manez R, Marina A, Wells J. Broadening the antibacterial spectrum of histidine kinase autophosphorylation inhibitors via the use of ε-poly-L-lysine capped mesoporous silica-based nanoparticles. Nanomedicine 2016; 13:569-581. [PMID: 27720925 DOI: 10.1016/j.nano.2016.09.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/02/2016] [Revised: 08/29/2016] [Accepted: 09/18/2016] [Indexed: 11/25/2022]
Abstract
Two-component systems (TCS) regulate diverse processes such as virulence, stress responses, metabolism and antibiotic resistance in bacteria but are absent in humans, making them promising targets for novel antibacterials. By incorporating recently described TCS histidine kinase autophosphorylation inhibitors (HKAIs) into ε-poly-L-lysine capped nanoparticles (NPs) we could overcome the Gram negative (Gr-) permeability barrier for the HKAIs. The observed bactericidal activity against Gr- bacteria was shown to be due to the enhanced delivery and internalization of the HKAIs and not an inhibitory or synergistic effect of the NPs. The NPs had no adverse effects on mammalian cell viability or the immune function of macrophages in vitro and showed no signs of toxicity to zebrafish larvae in vivo. These results show that HKAIs are promising antibacterials for both Gr- and Gr+pathogens and that NPs are a safe drug delivery technology that can enhance the selectivity and efficacy of HKAIs against bacteria.
Collapse
Affiliation(s)
- Nadya Velikova
- Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas (CSIC), Jaume Roig 11, Valencia, Spain; Host-Microbe Interactomics Chair Group, Animal Sciences, University of Wageningen, P.O. Box 338, The Netherlands.
| | - Nuria Mas
- Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Unidad Mixta Universitat Politècnica de València-Universitat de València, Departamento de Quimica, Univesidad Politecnica de Valencia, Camino de Vera s/n, 46022, Valencia, Spain; CIBER de Bioingeneria, Biomateriales y Nanomedicina, (CIBERBBN)
| | - Laura Miguel-Romero
- Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas (CSIC), Jaume Roig 11, Valencia, Spain
| | - Lorena Polo
- Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Unidad Mixta Universitat Politècnica de València-Universitat de València, Departamento de Quimica, Univesidad Politecnica de Valencia, Camino de Vera s/n, 46022, Valencia, Spain; CIBER de Bioingeneria, Biomateriales y Nanomedicina, (CIBERBBN)
| | - Ellen Stolte
- Host-Microbe Interactomics Chair Group, Animal Sciences, University of Wageningen, P.O. Box 338, The Netherlands
| | - Edoardo Zaccaria
- Host-Microbe Interactomics Chair Group, Animal Sciences, University of Wageningen, P.O. Box 338, The Netherlands
| | - Rui Cao
- Host-Microbe Interactomics Chair Group, Animal Sciences, University of Wageningen, P.O. Box 338, The Netherlands
| | - Nico Taverne
- Host-Microbe Interactomics Chair Group, Animal Sciences, University of Wageningen, P.O. Box 338, The Netherlands
| | - José Ramón Murguía
- Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Unidad Mixta Universitat Politècnica de València-Universitat de València, Departamento de Quimica, Univesidad Politecnica de Valencia, Camino de Vera s/n, 46022, Valencia, Spain; CIBER de Bioingeneria, Biomateriales y Nanomedicina, (CIBERBBN)
| | - Ramon Martinez-Manez
- Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Unidad Mixta Universitat Politècnica de València-Universitat de València, Departamento de Quimica, Univesidad Politecnica de Valencia, Camino de Vera s/n, 46022, Valencia, Spain; CIBER de Bioingeneria, Biomateriales y Nanomedicina, (CIBERBBN)
| | - Alberto Marina
- Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas (CSIC), Jaume Roig 11, Valencia, Spain; CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia, Spain
| | - Jerry Wells
- Host-Microbe Interactomics Chair Group, Animal Sciences, University of Wageningen, P.O. Box 338, The Netherlands
| |
Collapse
|
3
|
Stolte E. Capacity-related Interfacility Patient Transports: Patients Affected, Waiting Times, and Associated Morbidity. Acad Emerg Med 2004. [DOI: 10.1197/j.aem.2004.02.223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
4
|
Huising MO, Stolte E, Flik G, Savelkoul HFJ, Verburg-van Kemenade BML. CXC chemokines and leukocyte chemotaxis in common carp (Cyprinus carpio L.). Dev Comp Immunol 2003; 27:875-888. [PMID: 12880637 DOI: 10.1016/s0145-305x(03)00082-x] [Citation(s) in RCA: 88] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
CXC chemokines, structurally recognizable by the position of four conserved cysteine residues, are prominent mediators of chemotaxis. Here we report a novel carp CXC chemokine obtained through homology cloning and compare it with fish orthologues genes and with a second, recently elucidated, carp CXC chemokine. Phylogenetic analyses clearly show that neither CXC chemokine resembles any of the mammalian CXC chemokines in particular. However, basal expression is most prominent in immune organs like anterior kidney and spleen, suggesting involvement in the immune response. Furthermore we show that anterior kidney phagocyte-enriched leukocyte suspensions express both chemokines and that this expression is upregulated by brief (4 h) stimulation with PMA, but not lipopolysaccharide. Neutrophilic granulocyte-enriched leukocytes display chemotaxis to human recombinant CXCL8 (hrCXCL8; interleukin-8), confirming CXC chemokine mediated chemotaxis of neutrophilic granulocytes in teleost fish. Factors secreted from carp phagocytes are also capable of inducing chemotaxis and secretion of these factors into culture supernatants is upregulated by PMA. Finally we demonstrate involvement of both CXC chemokines as well as CXCR1 and CXCR2 in acute Argulus japonicus infection. Collectively the data presented implicate the involvement of CXC chemokines in chemotaxis of fish neutrophils in a fashion that shares characteristics with the mammalian situation. However, the CXC chemokines involved differ enough from those involved in neutrophil chemotaxis in mammals to warrant their own nomenclature.
Collapse
Affiliation(s)
- Mark O Huising
- Department of Cell Biology and Immunology, Wageningen Institute of Animal Sciences, Wageningen University, P.O. Box 338, 6700 AH Wageningen, The Netherlands
| | | | | | | | | |
Collapse
|
5
|
Hallscheidt P, Stolte E, Roeren T, Pomer S, Drehmer I, Kauffmann GW. [The staging of renal-cell carcinomas in MRT and CT--a prospective histologically controlled study]. ROFO-FORTSCHR RONTG 1998; 168:165-70. [PMID: 9519049 DOI: 10.1055/s-2007-1015202] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
PURPOSE To evaluate the accuracy of computed tomography (CT) and magnetic resonance imaging (MRI) in staging renal carcinoma. MATERIAL AND METHODS 33 renal carcinomas were preoperatively examined for tumour staging by CT and MR imaging and correlated with histopathological staging. CT imaging was performed at first as a non-contrast scan. Finally incremental images (10 mm) after intravenous contrast injection were obtained. In MR imaging we performed a transversal T1-weighted GE sequence (112/5) with and without GDTPA, a transversal fat-suppressed double-echo sequence (3900/22/90), a coronal T1-weighted GE sequence with and without GDTPA and a coronal T2-weighted TSE sequence (2800/128). In addition, dynamic T1-weighted GE imaging after GDTPA injection as well as TOF angiography in coronal direction were performed. Finally CT and MRI findings were correlated with surgical and histopathological staging results. RESULTS CT and MRI staging was correct in 27 and 28 of 33 tumours. Sensitivity and specificity for tumour stage T3b to T4 was for MRI and CT 88.9% and 95.8%. With MRI 4 out of 7 thrombi were correctly diagnosed with high accuracy, but via CT none. CONCLUSION In early stage renal carcinoma CT and MR imaging yielded similar staging accuracies. In advanced renal carcinoma MRI was superior to CT imaging, especially in diagnosing tumour thrombus. Consequently the extent of tumour thrombus may be assessed by MRI which may therefore replace conventional cavography.
Collapse
Affiliation(s)
- P Hallscheidt
- Abteilung Radiodiagnostik, Radiologische Klinik, Ruprecht-Karls-Universität Heidelberg
| | | | | | | | | | | |
Collapse
|
6
|
Neubert R, Ritter A, Stolte E, Albrecht G, Loh HJ, Jirka M, Fürst W. Influence of ion-pair-formation on the pharmacokinetic properties of drugs. Part 4: Influence of hexylsalicylic acid on the pharmacokinetics of bretylium. Pharmazie 1988; 43:848-50. [PMID: 3247377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Based on in vitro results it was found that the pharmacokinetic parameters of the hydrophilic drug bretylium (2) can be influenced by an ion-pair-formation with the lipophilic hexylsalicyclic acid (1). After simultaneous i.v. application of 1 and 2 on rabbits a significant increase of the AUC of 2 was observed. Under these conditions a marked increase of the AUC and the MRT of 1 was also obtained, since the blood levels of 2 are high enough for such an influence. A combined rectal application of 1 and 2 causes an increase of the AUC of 2.
Collapse
Affiliation(s)
- R Neubert
- Sektion Pharmazie, Martin-Luther-Universität Halle
| | | | | | | | | | | | | |
Collapse
|
7
|
Neubert R, Fürst W, Schleiermacher H, Bergmann P, Stolte E. [Drug transport through artificial lipoid membranes. 21. Ion pair transport with alkyl salicylic acids]. Pharmazie 1987; 42:309-11. [PMID: 3671439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Using hexylsalicylic acid it was demonstrated that alkylated derivatives of salicylic acid are able to increase partition and transport of ionized basic drugs across lipophilic membranes. The influence of different donor concentrations on the relation of transport was studied by means of pholedrine in combination with hexylsalicylic acid. In order to explain the mechanism of the ion-pair-transport experiments were carried out which show beside the mentioned increase of transport the occurrence of a countertransport of protons and lithium-ions, respectively. The lipophilic counterion hexylsalicylate acts inside of this mechanism as a carrier for the ionized drugs.
Collapse
Affiliation(s)
- R Neubert
- Sektion Pharmazie, Martin-Luther-Universität Halle-Wittenberg
| | | | | | | | | |
Collapse
|
8
|
Dennig HK, Schlipköter HW, Stolte E. Das Erythrogramm im Rekonvaleszenzstadium der Nagetiermalaria (Plasmodium berghei) nach Behandlung mit Camolar®. Med Microbiol Immunol 1970. [DOI: 10.1007/bf02124880] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|